Beyond Minoxidil: Evidence-Based Off-Label Therapies for Male Androgenetic Alopecia

The review explores off-label therapies for male androgenetic alopecia (AGA) beyond the FDA-approved treatments of oral finasteride and topical minoxidil. It synthesizes evidence on the efficacy and safety of alternative treatments such as topical finasteride, botulinum toxin, procyanidin, rosemary oil, and others. A network meta-analysis was conducted to compare these off-label therapies with minoxidil, focusing on hair density outcomes. The study aims to integrate mechanistic insights with clinical data to identify promising strategies for AGA management. The review included randomized and non-randomized studies, but specific sample sizes were not mentioned.